|
Delayed
Bombay S.E.
08:07:25 27/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 186.05 INR | 0.00% |
|
+18.54% | +126.26% |
| Market Cap | 54.61B 573M 491M 461M 421M 795M 799M 5.46B 2.12B 27.55B 2.15B 2.1B 91.25B | P/E 2027 * |
24.8x | P/E 2028 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 54.61B 573M 491M 461M 421M 795M 799M 5.46B 2.12B 27.55B 2.15B 2.1B 91.25B | EV / Sales 2027 * |
1.99x | EV / Sales 2028 * | 1.73x |
| Free-Float |
33.91% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : IOL Chemicals and Pharmaceuticals Limited
| 1 day | +0.03% | ||
| 1 week | +18.54% | ||
| Current month | +27.29% | ||
| 1 month | +22.68% | ||
| 3 months | +36.82% | ||
| 6 months | +151.76% | ||
| Current year | +126.26% |
| 1 week | 158 | 191.5 | |
| 1 month | 143.55 | 191.5 | |
| Current year | 67.14 | 191.5 | |
| 1 year | 67.14 | 191.5 | |
| 3 years | 57.51 | 191.5 | |
| 5 years | 54.44 | 191.5 | |
| 10 years | 8.4 | 191.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | 34 | - |
Pardeep Khanna
DFI | Director of Finance/CFO | - | - |
Abhay Raj Singh
CMP | Compliance Officer | - | 13/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Varinder Gupta
CHM | Chairman | 63 | 31/08/2007 |
Vikas Gupta
BRD | Director/Board Member | 34 | 28/05/2015 |
| Chairman | 73 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +18.54% | +102.83% | +142.29% | 573M | ||
| -3.59% | -7.10% | +61.60% | +114.83% | 1,060B | ||
| -1.15% | -1.25% | +52.98% | +62.41% | 651B | ||
| -1.09% | -1.15% | +26.18% | +79.22% | 465B | ||
| -0.76% | +0.24% | +42.09% | +42.09% | 365B | ||
| -0.76% | +0.05% | +25.57% | +41.75% | 300B | ||
| -0.15% | +1.53% | +3.05% | +13.24% | 258B | ||
| -0.43% | -0.46% | +52.06% | +71.75% | 238B | ||
| -1.39% | +1.84% | -13.11% | -52.28% | 210B | ||
| -0.46% | +0.33% | +29.05% | +92.67% | 184B | ||
| Average | -0.98% | +1.25% | +38.23% | +60.80% | 373.1B | |
| Weighted average by Cap. | -1.63% | -2.15% | +40.42% | +67.99% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 27.42B 288M 247M 232M 212M 399M 401M 2.74B 1.06B 13.84B 1.08B 1.06B 45.82B | 31.52B 331M 284M 266M 243M 459M 461M 3.15B 1.22B 15.9B 1.24B 1.21B 52.68B |
| Net income | 2.2B 23.05M 19.78M 18.57M 16.96M 32M 32.15M 220M 85.14M 1.11B 86.53M 84.65M 3.67B | 2.84B 29.78M 25.56M 23.99M 21.91M 41.35M 41.55M 284M 110M 1.43B 112M 109M 4.75B |
| Net Debt | - | - |
Employees
3,095
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/08/26 | ₹186.05 | 0.00% | 376,362 |
| 26/08/26 | ₹186.05 | +7.89% | 904,029 |
| 25/08/26 | ₹172.45 | +1.92% | 285,009 |
| 24/08/26 | ₹169.20 | -0.21% | 291,080 |
| 21/08/26 | ₹169.55 | +3.51% | 435,008 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
186.05INR
Average target price
197.00INR
Spread / Average Target
+5.89%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IOLCP Stock
Select your edition
All financial news and data tailored to specific country editions
















